Does Aetna (CVS Health) Cover Enclomiphene Citrate?
Aetna (CVS Health) may cover enclomiphene citrate for secondary hypogonadism with prior authorization and step therapy. Learn PA criteria, appeal steps, formulary tier, and cost details.
Enclomiphene
71 source-based articles maintained by the HealthRX.com Editorial Team.
71articles
7topic areas covered
May 26, 2026latest review
Enclomiphene library
Showing 60 of 71 clinical reviews.
Does Anthem (Elevance Health) Cover Enclomiphene Citrate?
A clinical guide to Anthem (Elevance Health) coverage, prior authorization criteria, step therapy requirements, and appeal strategies for enclomiphene citrate prescriptions.
Does Blue Cross Blue Shield (Federated) Cover Enclomiphene Citrate?
Find out whether Blue Cross Blue Shield Federated plans cover enclomiphene citrate for secondary hypogonadism, including prior authorization criteria, formulary status, step therapy rules, and how to appeal a denial.
Does Cigna Cover Enclomiphene Citrate?
A clinical and insurance guide to Cigna coverage, prior authorization, step therapy, and appeal strategies for enclomiphene citrate prescriptions. prepared by the HealthRX.com Editorial Team.
Does Medicare Advantage Cover Enclomiphene Citrate?
Medicare Advantage plans rarely cover enclomiphene citrate because it lacks standalone FDA approval. Learn about formulary status, prior authorization, appeals, and affordable alternatives.
Does State Medicaid Cover Enclomiphene Citrate?
A state-by-state guide to Medicaid coverage, prior authorization, step therapy, and appeal strategies for enclomiphene citrate prescribed for secondary hypogonadism.
Does TRICARE Cover Enclomiphene Citrate?
How to check a current TRICARE benefit for enclomiphene citrate without relying on generic approval, pricing, or prior-authorization claims.
Enclomiphene Citrate Adolescent (12 to 17) Dosing: What Clinicians Need to Know
A comprehensive clinical guide to enclomiphene citrate dosing in adolescents aged 12, 17 with secondary hypogonadism, covering off-label rationale, dose ranges, monitoring protocols, and safety considerations prepared by the HealthRX.com Editorial Team.
Enclomiphene Citrate Adult (30 to 49) Monitoring: Complete Clinical Guide
A guide to monitoring enclomiphene citrate therapy in men aged 30, 49, covering lab schedules, dose adjustments, safety endpoints, and when to stop treatment.
Enclomiphene Citrate Adult (30-49) Dosing: Complete Clinical Guide
Evidence-based dosing guide for enclomiphene citrate in men aged 30-49 with secondary hypogonadism. Covers starting doses, titration, monitoring, and clinical trial data prepared by the HealthRX.com Editorial Team.
Enclomiphene Citrate After Bariatric Surgery: Clinical Use, Dosing, and What the Evidence Actually Shows
A physician-level review of enclomiphene citrate for secondary hypogonadism in post-bariatric men: pharmacokinetics, absorption concerns, dosing adjustments, monitoring targets, and the evidence base including Kim et al. 2016.
Enclomiphene Citrate and Cognitive Function: What the Evidence Actually Shows
A analysis of how enclomiphene citrate affects cognitive function, mood, and brain health in men with secondary hypogonadism, including clinical trial data, proposed mechanisms, and dosing context.
Enclomiphene Citrate and Sleep Architecture: What the Evidence Shows
A deep dive into how enclomiphene citrate affects sleep architecture, REM sleep, slow-wave sleep, and testosterone-driven circadian signaling in men with secondary hypogonadism.
Enclomiphene Citrate Appetite & Cravings Changes: What the Evidence Shows
Does enclomiphene citrate change appetite or cravings? A clinician-level review of the mechanisms, clinical trial data, and practical guidance for men on enclomiphene therapy.
Enclomiphene Citrate Autoimmune Disease Considerations
A clinician-level review of enclomiphene citrate use in patients with autoimmune disease, covering pharmacology, immune-axis interactions, trial data, and practical prescribing guidance for secondary hypogonadism.
Enclomiphene Citrate Bone Health and Density Impact
A clinician-level review of how enclomiphene citrate affects bone mineral density, estradiol signaling, and fracture risk in men with secondary hypogonadism, with primary-literature citations throughout.
Enclomiphene Citrate Cancer Risk Signal Review
A physician-level review of the cancer risk signals associated with enclomiphene citrate, covering estrogen receptor pharmacology, published trial safety data, and how clinicians should counsel patients on off-label use for secondary hypogonadism.
Enclomiphene Citrate Cardiovascular Impact: Long-Term Evidence Review
A clinician-level review of enclomiphene citrate's cardiovascular effects in men with secondary hypogonadism, covering lipid profiles, blood pressure, erythrocytosis risk, and how it compares to exogenous testosterone therapy.
Enclomiphene Citrate Cost vs. Alternatives in Class
A clinical comparison of enclomiphene citrate pricing, efficacy, and side-effect profile against clomiphene, tamoxifen, anastrozole, hCG, and exogenous testosterone for secondary hypogonadism.
Enclomiphene Citrate Dosing for Older Adults (Ages 50 to 64)
A guide to enclomiphene citrate dosing in the 50, 64 age group, covering starting doses, titration, monitoring labs, cardiovascular considerations, and how older-adult physiology changes the risk-benefit calculation.
Enclomiphene Citrate Dosing for Young Adults (18 to 29): Evidence, Protocols, and Monitoring
Clinical dosing guide for enclomiphene citrate in young adults aged 18 to 29 with secondary hypogonadism, covering starting doses, titration, lab monitoring, and fertility preservation.
Enclomiphene Citrate Dosing in Hepatic Impairment
Evidence-based guidance on enclomiphene citrate dose adjustments for patients with liver disease, including Child-Pugh-based recommendations, monitoring protocols, and alternative strategies.
Enclomiphene Citrate Dosing in Renal Impairment
Evidence-based guidance on enclomiphene citrate dosing for patients with renal impairment, including pharmacokinetic considerations, CKD-related hypogonadism, and monitoring recommendations.
Enclomiphene Citrate Drug-Drug Interactions: A Complete Clinical Profile
Full drug-drug interaction profile for enclomiphene citrate, including CYP enzyme effects, hormonal co-therapies, and safety data from clinical studies.
Enclomiphene Citrate Evidence Base Graded by GRADE
A GRADE-graded review of every major enclomiphene citrate trial, covering testosterone restoration, spermatogenesis, and how the evidence compares to clomiphene and exogenous TRT for secondary hypogonadism.
Enclomiphene Citrate Food & Supplement Interactions
A clinical guide to food and supplement interactions with enclomiphene citrate, including CYP enzyme effects, phytoestrogens, fat-soluble nutrient timing, and supplements that may alter efficacy.
Enclomiphene Citrate for Secondary Hypogonadism: Evidence, Dosing, and What to Expect
A comprehensive clinical review of enclomiphene citrate for secondary hypogonadism: how it works, what the trial data show, dosing protocols, side effects, and who qualifies for treatment.
Enclomiphene Citrate Geriatric (65+) Dosing: What Older Men Need to Know
A guide to enclomiphene citrate dosing in men aged 65 and older, covering starting doses, titration, renal and hepatic adjustments, fall risk, drug interactions, and monitoring protocols for secondary hypogonadism.
Enclomiphene Citrate Geriatric (65+) Monitoring: Lab Schedule, Safety Checks, and Dose Adjustments
Evidence-based monitoring protocol for enclomiphene citrate in adults 65 and older, covering lab timing, cardiovascular screening, drug interactions, and deprescribing criteria.
Enclomiphene Citrate Hair and Skin Changes: What the Clinical Evidence Shows
What enclomiphene trials measured, what remains unknown about hair loss and acne, and how to evaluate changes without inventing DHT thresholds or protocols.
Enclomiphene Citrate in Adults 65 and Older: What the Evidence Says About Safety
A clinical review of enclomiphene citrate safety in geriatric patients (65+), covering cardiovascular risk, drug interactions, renal considerations, and monitoring protocols for older men with secondary hypogonadism.
Enclomiphene Citrate in Special Populations: Transplant, HIV, Chronic Disease, and Beyond
Evidence-based guide to enclomiphene citrate use in special populations including organ transplant recipients, people living with HIV, chronic kidney disease, liver disease, and older adults.
Enclomiphene Citrate Liver Function Impact: What the Clinical Evidence Shows
A deep dive into how enclomiphene citrate affects liver enzymes, hepatic metabolism, and long-term liver safety, with primary-literature citations throughout.
Enclomiphene Citrate Manufacturing, Supply & Shortage History
A clinical deep-dive into enclomiphene citrate's manufacturing origins, FDA regulatory status, compounding pharmacy supply chains, and the shortage events that have shaped patient access since 2012.
Enclomiphene Citrate Mechanism of Action: The Full Hormonal Pathway Explained
A physician-level explanation of how enclomiphene citrate restores testosterone through hypothalamic estrogen receptor antagonism, GnRH upregulation, and downstream gonadotropin signaling while preserving spermatogenesis.
Enclomiphene Citrate Mental Health and Mood Impact
A clinical deep-dive into how enclomiphene citrate affects mood, cognition, and mental health in men with secondary hypogonadism, with primary-literature citations and practical prescribing guidance.
Enclomiphene Citrate Microdosing Protocols: What the Evidence Actually Shows
A deep dive into enclomiphene citrate microdosing protocols for secondary hypogonadism, covering clinical trial data, dose-titration strategies, monitoring parameters, and how microdosing compares to standard dosing.
Enclomiphene Citrate Missed-Dose Protocol
What to do if you miss a dose of enclomiphene citrate, how its pharmacokinetics inform safe catch-up timing, and when to simply skip and resume your regular schedule.
Enclomiphene Citrate Monitoring for Older Adults (Ages 50 to 64): A Complete Clinical Guide
A guide to monitoring enclomiphene citrate in adults aged 50, 64, covering lab schedules, cardiovascular risk, polypharmacy, and dose adjustments for secondary hypogonadism.
Enclomiphene Citrate Monitoring for Young Adults (Ages 18 to 29)
A complete clinical guide to monitoring enclomiphene citrate in men aged 18, 29 with secondary hypogonadism, covering lab schedules, fertility preservation, dose adjustments, and safety checkpoints prepared by the HealthRX.com Editorial Team.
Enclomiphene Citrate Monitoring in Adolescents (Ages 12 to 17): A Clinical Guide
A detailed clinical guide to monitoring enclomiphene citrate therapy in adolescent males aged 12-17 with secondary hypogonadism, covering lab schedules, growth surveillance, mental health tracking, and safety thresholds.
Enclomiphene Citrate Monitoring Schedule: Labs and Exams You Need
Evidence-based monitoring schedule for enclomiphene citrate therapy, including baseline labs, follow-up blood work timelines, and clinical exams required during treatment for secondary hypogonadism.
Enclomiphene Citrate Off-Label Uses: Evidence Levels, Mechanisms, and Clinical Applications
A guide to enclomiphene citrate off-label uses, covering secondary hypogonadism, male infertility, PCOS, and more, with evidence grades, named trials, doses, and primary-source citations.
Enclomiphene Citrate Overdose and Accidental Excess Dose: Recognition, Risks, and Clinical Management
A cautious, evidence-boundary guide to enclomiphene citrate overdose recognition and accidental excess dose management, prepared for editorial and qualified medical review.
Enclomiphene Citrate Patent Field and Generic Timeline
A deep dive into enclomiphene citrate's mechanism, patent history, FDA regulatory status, and when a generic version is realistically expected.
Enclomiphene Citrate Pediatric (Under 12) Dosing: What Clinicians and Parents Need to Know
A comprehensive clinical review of enclomiphene citrate dosing considerations for children under 12, covering FDA labeling status, off-label use rationale, safety monitoring, and the absence of pediatric trial data.
Enclomiphene Citrate Pediatric (Under 12) Monitoring: Clinical Protocols and Safety
Evidence-based monitoring protocols for enclomiphene citrate use in pediatric patients under 12, including laboratory parameters, growth tracking, and safety considerations.
Enclomiphene Citrate Pediatric (Under 12) Safety
No clinical trials have tested enclomiphene citrate in children under 12. This article covers the absence of pediatric data, risks of SERM exposure in prepubertal children, and why pediatric endocrinologists use different approaches for childhood hormonal conditions.
Enclomiphene Citrate Pharmacogenomics and Genetic Variability
How CYP2D6, CYP3A4, ESR1, and other gene variants influence enclomiphene citrate response, dosing, and side-effect risk in men with secondary hypogonadism.
Enclomiphene Citrate Pharmacokinetics (ADME): Absorption, Distribution, Metabolism, and Excretion
An evidence-based deep dive into enclomiphene citrate pharmacokinetics covering absorption, protein binding, CYP-mediated metabolism, half-life, and clinical relevance for treating secondary hypogonadism.
Enclomiphene Citrate Plateau & Non-Response Troubleshooting
A structured approach to diagnosing why testosterone stalls on enclomiphene citrate: how to tell a lab-timing artifact from SHBG elevation, thyroid or prolactin interference, medication effects, or primary testicular failure, and when to reconsider the plan.
Enclomiphene Citrate Pre-Surgery Hold Window: Clinical Guide
When and how long to hold enclomiphene citrate before surgery, with evidence-based dosing, pharmacokinetics, and perioperative management protocols for clinicians and patients.
Enclomiphene Citrate Real-World Evidence: What Registries and RWE Studies Actually Show
A clinician-level review of enclomiphene citrate real-world evidence, including registry data, RWE studies, mechanism of action, dosing, and how it compares to TRT for secondary hypogonadism.
Enclomiphene Citrate Rebound Effects When Stopping: What the Evidence Shows
A deep dive into what happens to testosterone, LH, FSH, and spermatogenesis after stopping enclomiphene citrate, including timeline data, risk factors, and clinical restart protocols.
Enclomiphene Citrate Regulatory Status: US, EU, Canada, and UK
Enclomiphene has no FDA approval as of 2026: the FDA issued three Complete Response Letters through 2015. US access remains via 503A and 503B compounding.
Enclomiphene Citrate Safety in Adolescents Ages 12 to 17
A clinical evidence review of enclomiphene citrate use in adolescents aged 12 to 17: what adult and pediatric-adjacent data show, what is unstudied, and the monitoring and consent standards this age group requires.
Enclomiphene Citrate Safety in Adults (30 to 49): What the Evidence Shows
A guide to enclomiphene citrate safety for adults aged 30 to 49, covering side effects, cardiovascular risks, liver monitoring, fertility preservation, and off-label prescribing considerations.
Enclomiphene Citrate Safety in Older Adults Ages 50 to 64
A clinical review of enclomiphene citrate safety for men ages 50 to 64, covering cardiovascular risk, polypharmacy interactions, dosing, monitoring protocols, and what current evidence says about long-term use in the andropause window.
Enclomiphene Citrate Safety in Young Adults (18 to 29): What the Evidence Shows
A guide to enclomiphene citrate safety for men aged 18, 29, covering testosterone restoration, fertility preservation, adverse effects, monitoring protocols, and current guideline positions.
Enclomiphene Citrate Self-Injection Technique: Why This Oral Drug Does Not Require Injections
Enclomiphene citrate is an oral medication for secondary hypogonadism, not an injectable. Learn how enclomiphene works, how to take it correctly, and how it compares to injectable testosterone therapy.
Showing the first 60 matches among the loaded articles. Use the page links below to browse the complete library.
